News Bulletin
Monday, March 30th, 2026
Evening Edition
Economic Numbers:
|
Time |
Event |
Actual |
Forecast |
Previous |
|
Monday, March 30th, 2026 |
||||
|
10:30 |
Fed Chair Powell Speaks |
|
|
|
|
10:30 |
Dallas Fed Mfg Business Index (Mar) |
-0.2 |
|
0.2 |
|
11:30 |
3-Month Bill Auction |
3.62% |
|
3.64% |
|
15:47 |
6-Month Bill Auction |
3.61% |
|
3.63% |
|
11:30 |
|
|
|
|
|
16:00 |
FOMC Member Williams Speaks |
|
|
|
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
DJIA |
45,216.66 |
48,319.71 |
46,657.76 |
|
NASDAQ |
20,794.64 |
22,704.27 |
22,306.45 |
|
S&P 500 |
6,343.72 |
6,801.78 |
6,636.35 |
Earnings Calendar:
(EPS: Earning Per Share / Rev: Revenue / Mkt Cap : market Capital/ BMO :
Before Market Opening /AMC : After Market Close)
|
NAME |
COMPANY |
Mkt CAP |
EPS (Forcast) |
EPS (Actual) |
Revenue (Forcast) |
Revenue (Actual) |
Time |
|
GGDVY |
Guangdong
Investment |
$6.29B |
|
|
|
|
|
|
BHKLY |
BOC
Hong Kong (Holdings) |
$55.30B |
3.84 |
|
$4.56B |
|
|
|
SOTGY |
Sunny
Optical Technology (Group) |
$7.50B |
|
|
|
|
|
|
SSVFF |
Southern
Silver Exploration |
C$151.33M |
|
|
|
|
|
|
CSUAY |
China
Shenhua Energy Company |
$143.36B |
|
|
|
|
|
|
MAAS |
Highest
Performances Holdings |
$1.77B |
|
|
|
|
|
|
BACHY |
Bank
of China |
$239.07B |
0.71 |
|
|
|
|
|
BLNE |
Beeline
Holdings |
$62.23M |
-0.31 |
|
$2.71M |
|
|
|
BOC |
Boston
Omaha |
$370.52M |
-0.03 |
|
$29.00M |
|
|
|
PRGS |
Progress
Software |
$1.17B |
1.57 |
|
$246.41M |
|
|
|
RVPH |
Reviva Pharmaceuticals Holdings |
$9.44M |
-1.09 |
(-404.6%) -$5.48 |
0 |
|
|
|
TPST |
Tempest
Therapeutics |
$23.32M |
-0.62 |
(-920.97%) -$6.33 |
0 |
|
|
|
BCAX |
Bicara Therapeutics Inc. |
$1.16B |
-0.67 |
(-2.26%) -$0.68 |
0 |
|
BMO |
|
MEDIF |
MediPharm Labs |
$19.69M |
>-$0.01 |
|
$8.51M |
(+29.96%) +$11.062M |
BMO |
|
USAS |
Americas
Gold and Silver |
$1.50B |
0.03 |
(-1,278.57%) -$0.33 |
$47.50M |
(+148.42%) +$118M |
BMO |
|
SGML |
Sigma
Lithium |
$1.17B |
-0.01 |
|
$22.61M |
|
BMO |
|
NMRA |
Neumora Therapeutics, Inc. |
$389.32M |
-0.32 |
(-8.7%) -$0.35 |
0 |
|
BMO |
|
IMSR |
Terrestrial
Energy |
$491.45M |
-0.2 |
(0%) -$0.2 |
0 |
|
BMO |
|
FRMI |
Fermi
Inc. |
$3.79B |
-0.01 |
(-11,200%) -$1.13 |
$6.04M |
|
BMO |
|
PDSB |
PDS
Biotechnology |
$29.63M |
-0.2 |
|
0 |
|
BMO |
|
CBAT |
CBAK
Energy Technology |
$72.25M |
-0.03 |
|
$65.00M |
(-9.53%) +$58.803M |
BMO |
|
INLX |
Intellinetics |
$32.47M |
-0.08 |
|
$4.14M |
|
AMC |
|
INV |
Innventure |
$300.47M |
-0.32 |
|
$2.01M |
|
AMC |
|
AIRJ |
Montana
Technologies |
$196.49M |
-0.07 |
|
-$1.00M |
|
AMC |
|
HQI |
HireQuest |
$140.15M |
0.13 |
|
$7.40M |
|
AMC |
|
ZSPC |
zSpace, Inc. |
$4.09M |
-0.18 |
|
$6.20M |
|
AMC |
|
FTHM |
Fathom
Holdings |
$23.00M |
-0.11 |
|
$97.50M |
|
AMC |
|
LTRN |
Lantern
Pharma |
$12.53M |
-0.46 |
|
0 |
|
AMC |
|
DMRA |
Damora Therapeutics |
$1.54B |
0.9 |
(-459.53%) -$3.243 |
0 |
$0 |
AMC |
|
PHR |
Phreesia |
$661.95M |
0.07 |
|
$126.65M |
|
AMC |
|
DFDV |
DeFi
Development Corporation |
$106.42M |
-0.07 |
|
$4.10M |
|
AMC |
|
DMAC |
Diamedica Therapeutics |
$353.61M |
-0.18 |
|
0 |
|
AMC |
|
IVA |
Inventiva |
$1.19B |
-0.28 |
|
0 |
|
AMC |
|
INMB |
Inmune Bio |
$29.78M |
-0.26 |
|
0 |
|
AMC |
|
SGMO |
Sangamo Biosciences |
$119.27M |
<$0.01 |
|
$40.23M |
|
AMC |
|
SPCE |
Virgin
Galactic Holdings |
$165.27M |
-1.03 |
|
$412.00K |
|
AMC |
Market
News:
Wall Street fell on Monday, as an attempt at a tentative rebound from
earlier in the session petered out. A brutal sell-off in bonds eased up
following some positive comments from Federal Reserve Chair Jerome Powell.
The ongoing Middle East conflict remained squarely in the spotlight, with
further mixed messaging on the state of peace talks between the U.S. and Iran.
At 15:15 ET (19:15 GMT), the benchmark S&P 500 index was down
0.7% to 6,325.85 points, reversing a climb of as much as 0.9%. The tech-heavy NASDAQ
Composite shed 1.1% to 20,719.16 points, erasing a gain of as much as 0.9%.
The blue-chip Dow Jones Industrial Average had also slipped into
negative territory, down 0.1% to 45,109.05 points.
Carlyle
Group Inc. (NASDAQ:CG) plans to launch a fund focused on the defense sector amid growing demand by governments to
upgrade their military forces, according to reporting from Bloomberg, citing
people with knowledge of the matter. Carlyle stock gained 1.8% in late
afternoon trade following the news.
The Washington, DC-based firm has reached out to investors to discuss the
fund, pitching it as a way to invest in so-called reindustrialization, the
people said, who asked not to be identified discussing confidential
information. This entails expanding the US’s industrial base and manufacturing.
Citigroup Inc. is approaching other lenders to join a roughly $4.8
billion financing backing Ecolab Inc.’s (NYSE:ECL) purchase of CoolIT Systems Inc., according to reporting from Bloomberg,
citing people with knowledge of the matter. The deal will likely involve
selling investment-grade bonds, the people said.
Ecolab, a St. Paul, Minnesota-based company that provides water and
hygiene services to commercial and industrial businesses, announced earlier
this month its plan to buy CoolIT from funds managed
by KKR & Co. (NYSE:KKR) for $4.75 billion in cash. CoolIT develops cooling technology for AI data centers.
Lucid Group
Inc stock reached a 52-week low, hitting $9.12, underscoring a challenging
year for the electric vehicle manufacturer. The company’s market capitalization
now stands at approximately $2.99 billion. Over the past year, Lucid Group has
experienced a significant decline, with its stock price falling by roughly 59%.
This downturn reflects broader market pressures and specific challenges within
the electric vehicle sector.
Apple
removed the vibe coding app Anything from its App
Store on Thursday, according to Dhruv Amin, co-founder and CEO of the startup
behind the app. The removal came one week after Apple blocked updates to vibe
coding apps while allowing earlier versions to remain available in the store,
according to The Information.
Nike
stock has reached a 52-week low, hitting $51.20 as the company faces a
turbulent year. The stock has fallen even harder in recent months, posting a
25% decline over the past six months. This marks a significant downturn,
reflecting a 19.25% decline over the past year. The sportswear giant has been
grappling with various challenges, including supply chain disruptions and shifting
consumer preferences, which have impacted its financial performance. The recent
low underscores the difficulties Nike has encountered in maintaining its market
position amidst a volatile economic environment.
Boston
Scientific (NYSE:BSX) shares fell 9% after the company’s
CHAMPION-AF trial results for its Watchman heart implant failed to meet
investor expectations, despite meeting primary endpoints.
The trial examined the Watchman FLX Left Atrial
Appendage Closure device compared to non-vitamin K antagonist oral
anticoagulants as a first-line option for stroke risk reduction in patients
with non-valvular atrial
fibrillation. While the trial met all primary and secondary safety and efficacy
endpoints, the device showed a slightly higher ischemic stroke rate compared to
NOACs.
Goldman
Sachs stated that multi-asset portfolios remain
vulnerable to stagflationary shock in the near-term
as global equities extended their decline last week amid rising oil prices and
continued Middle East conflict.
The bank noted that oil flows through the Strait of Hormuz remain low
with limited offsets from pipelines, despite hopes for negotiations between the
US and Iran. Global front-end rates have somewhat stabilized despite continued
upward pressure on oil prices.
For
internal use only